![]() |
|||||||||||||
|
All | Since 2019 | |
Citation | 5450 | 3969 |
h-index | 23 | 20 |
i10-index | 134 | 84 |
SIX SIGMA IN THE PHARMACEUTICAL INDUSTRY: AN OVERVIEW
Om Babanrao Pande*, Dr.R.H Kale, Dr. Ashish Gawai, Dr.K.R Biyani
ABSTRACT
Six sigma is a process that examines the imperfections and deficiencies in an organisation. It helps the organization in delivering quality items at a cheaper that will satisfy client. Six sigma has evolved into one of the most potent approaches for quality assurance, business and issue resolution. An introduction to six sigma, a popular process methodology used by business to increase productivity, cut expenses, and improve the quality of their products and services. Six sigma is mainly utilizes two methodologies: DMAIC [Define, Measure, Analysis, Improve, Control] which revises the flaws in current cycles, furthermore DMADV [Define, Measure, Analyse, Design, Verify] which begins a new process when the former one altogether fails to achieve its objective and targets. Just few drug organisations are members of ISSSP [International Society of Six Sigma Professionals] i.e. Novartis, Eli Lilly, Johnson and Johnson. Implementation of Six Sigma is mainly reliant upon supporting infrastructure and Keywords: Six Sigma, DMAIC, Pharmaceutical industry. [Download Article] [Download Certifiate] |